Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer.

OBJECTIVE The purpose of our study was to evaluate the diagnostic accuracy of FDG positron emission tomography (PET) in comparison with CT in detecting recurrent ovarian carcinoma and its ability to reveal small tumor recurrence. MATERIALS AND METHODS We reviewed the records of 31 consecutive patients with pathologically proven epithelial carcinoma who underwent FDG PET 1 month before second-look surgery to assess recurrent tumor. Of these 31 patients, 21 patients also underwent CT 1 month before second-look surgery. The diagnostic accuracies of FDG PET (n = 31), CT (n = 21), and combined FDG PET and CT (n = 21) in detecting recurrent tumor were calculated and compared with each other using the Bennett's test in 21 patients who underwent both imaging studies. Detection rates of individual tumors relative to their sizes were compared between FDG PET and CT using the McNemar test. RESULTS The sensitivity, specificity, and accuracy of FDG PET, CT, and combined FDG PET and CT for revealing recurrent ovarian cancer were 45.3%, 99.7%, 91.0%; 54.5%, 99.6%, 91.7%; 58.2%, 99.6%, 92.4%, respectively. We found no statistically significant difference in the diagnostic accuracy of FDG PET, CT, and combined FDG PET and CT (chi(2) < 5.991). Detection rates of tumor nodules found on CT were significantly greater than those on FDG PET when nodule size was 0.3-0.7 cm (p < 0.05). CONCLUSION FDG PET did not improve the overall diagnostic accuracy in detecting recurrent ovarian carcinoma compared with CT. Rather, FDG PET was inferior to CT in its ability to reveal small-tumor recurrence.

[1]  K. Horton,et al.  Thin Section Dual‐Phase Multidetector‐Row Computed Tomography Detection of Peritoneal Metastases in Gynecologic Cancers , 2003, Journal of computer assisted tomography.

[2]  S. Waggoner,et al.  Effect of nicotine on proliferation of normal, malignant, and human papillomavirus-transformed human cervical cells. , 1994, Gynecologic oncology.

[3]  R. Low,et al.  Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT. , 1995, Radiology.

[4]  A. Megibow,et al.  Accuracy of CT in detection of persistent or recurrent ovarian carcinoma: correlation with second-look laparotomy. , 1988, Radiology.

[5]  B. Karlan,et al.  Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma. , 1993, Gynecologic oncology.

[6]  R. Halvorsen,et al.  Intraperitoneal contrast material improves the CT detection of peritoneal metastases. , 1991, AJR. American journal of roentgenology.

[7]  J. Keyes.  SUV: standard uptake or silly useless value? , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  K. Togashi,et al.  Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. , 2001, AJR. American journal of roentgenology.

[9]  S. Rubin,et al.  Second-look surgery in ovarian carcinoma. , 1988, Critical reviews in oncology/hematology.

[10]  N. Colombo,et al.  A reassessment of the role of second-look laparotomy in advanced ovarian cancer. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  R. Zepp,et al.  Ovarian carcinoma: value of CT in predicting success of debulking surgery. , 1995, AJR. American journal of roentgenology.

[12]  N. Weiss,et al.  Second thoughts about second-look laparotomy in advanced ovarian cancer. , 1990, The New England journal of medicine.

[13]  Bennett Bm.  On comparisons of sensitivity, specificity and predictive value of a number of diagnostic procedures. , 1972 .

[14]  J. Curtin,et al.  The follow-up of ovarian cancer. , 2003, Seminars in oncology.

[15]  W. Hoskins.  Epithelial ovarian carcinoma: principles of primary surgery. , 1994, Gynecologic oncology.

[16]  W. Hoskins.  Surgical staging and cytoreductive surgery of epithelial ovarian cancer , 1993, Cancer.

[17]  H Loats,et al.  CT and SPECT image registration and fusion for spatial localization of metastatic processes using radiolabeled monoclonals. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  R. Fisher,et al.  Peritoneoscopy in the management of ovarian cancer. , 1981, American journal of obstetrics and gynecology.

[19]  N. Gupta,et al.  Experience with positron emission tomography (PET) scans in patients with ovarian cancer. , 1994, Gynecologic oncology.

[20]  F. Abdul-Karim,et al.  Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy. , 2001, Gynecologic oncology.

[21]  R. Angioli,et al.  Systemic therapy for gynecological neoplasms: ovary, cervix and endometrium. , 2003, Cancer chemotherapy and biological response modifiers.

[22]  R. Golding,et al.  Comparative evaluation of diagnostic methods in ovarian carcinoma with emphasis on CT and MRI. , 1994, Gynecologic oncology.

[23]  B. M. Bennett.  On comparisons of sensitivity, specificity and predictive value of a number of diagnostic procedures. , 1972, Biometrics.

[24]  E. Fishman,et al.  Multidetector CT of peritoneal carcinomatosis from ovarian cancer. , 2003, Radiographics : a review publication of the Radiological Society of North America, Inc.

[25]  P. Silverman,et al.  CT prior to second-look operation in ovarian cancer. , 1988, AJR. American journal of roentgenology.

[26]  E. Dreher,et al.  Computed Tomography Prior to Second‐Look Operation in Advanced Ovarian Cancer , 1983, Obstetrics and gynecology.

[27]  G. V. von Schulthess,et al.  Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma , 2000, European Radiology.

[28]  B. Sevin,et al.  The role of radioimmunoscintigraphy and computed tomography scan prior to reassessment laparotomy of patients with ovarian carcinoma: A preliminary report , 1996, Cancer.

[29]  N. Teng,et al.  A critical reassessment of second‐look laparotomy in epithelial ovarian carcinoma , 1986, Cancer.

[30]  C. Yuan,et al.  Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent ovarian carcinoma. Initial report. , 1999, The Journal of reproductive medicine.

[31]  J. Juni,et al.  lndium-111 Oncoscint CR/OV and F-18 FDG in Colorectal and Ovarian Carcinoma Recurrences Early Observations , 1995, Clinical nuclear medicine.

[32]  H. Schoellnast,et al.  Digital image fusion of CT and PET data sets--clinical value in abdominal/pelvic malignancies. , 2000, Journal of computer assisted tomography.

[33]  J M Hoffman,et al.  Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  Raymond A. Lee,et al.  Recurrent disease after negative second-look laparotomy in stages III and IV ovarian carcinoma , 1988 .

[35]  M. Zimny,et al.  The role of 18F-fluoro-deoxyglucose positron emission tomography (18F-FDG PET) in diagnosis of ovarian cancer. , 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[36]  K. Hubner,et al.  Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG). , 1993, Gynecologic oncology.

[37]  R. Nelson,et al.  Peritoneal carcinomatosis: preoperative CT with intraperitoneal contrast material. , 1992, Radiology.

[38]  E. Atkinson,et al.  Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer. , 1997, Gynecologic oncology.

[39]  J. Cain,et al.  Recurrence after negative second-look laparotomy for ovarian cancer: analysis of risk factors. , 1988, American journal of obstetrics and gynecology.

[40]  N. Meyers,et al.  H = W. , 1964, Proceedings of the National Academy of Sciences of the United States of America.

[41]  H. Hricak,et al.  Imaging of ovarian cancer , 1995, Journal of magnetic resonance imaging : JMRI.

[42]  E. Petru,et al.  The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy, and high-dose radiotherapy. , 1999, Gynecologic oncology.

[43]  M. Berman.  Future directions in the surgical management of ovarian cancer. , 2003, Gynecologic oncology.

[44]  A. Govoni.  Peritoneal implants from ovarian tumors: CT findings , 1989 .